Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes-Reference-Cited by-同舟云学术

Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes

Published:2009-03 Issue:3 Volume:29 Page:424-430
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Ray Kausik K.¹,Cannon Christopher P.¹,Cairns Richard¹,Morrow David A.¹,Ridker Paul M¹,Braunwald Eugene¹

Affiliation:

1. From the TIMI Study Group, Cardiovascular Division and the Department of Medicine (C.P.C., D.A.M., E.B.), Brigham and Women’s Hospital/Harvard Medical School, Boston, Mass; the Department of Public Health and Primary Care (K.K.R.), University of Cambridge, UK; Worldwide Clinical Trials (R.C.), and the Donald W. Reynolds Center for Cardiovascular Research and the Center for Cardiovascular Disease Prevention (P.M.R.), Brigham and Women’s Hospital, Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference17 articles.

1. Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment

2. Non–HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women

3. Non–High-Density Lipoprotein Cholesterol and Apolipoprotein B in the Prediction of Coronary Heart Disease in Men

4. Prognostic value of apolipoprotein B and A-I in the prediction of myocardial infarction in middle-aged men and women: results from the MONICA/KORA Augsburg cohort study

5. Clinical Utility of Different Lipid Measures for Prediction of Coronary Heart Disease in Men and Women

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensive early and sustained lowering of non–high-density lipoprotein cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry;European Heart Journal;2024-09-01

2. Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: An expert clinical consensus from the national lipid association;Journal of Clinical Lipidology;2024-09

3. The Efficacy of Atorvastatin and Rosuvastatin on the Changes of alpha and beta Apolipoproteins; A Systematic Review and Meta-Analysis;Journal of Advances in Medical and Biomedical Research;2023-03-01

4. Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022;Journal of Atherosclerosis and Thrombosis;2023

5. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab;Circulation;2022-08-30